ICMR nod to Vishat Diagnostics COVID-19 antigen testing kit priced at Rs 425

Published On 2020-07-25 05:49 GMT | Update On 2020-07-25 05:49 GMT

New Delhi: Mumbai-based firm Vishat Diagnostics on Friday said it has received approval from the Indian Council of Medical Research (ICMR) for supplying COVID-19 rapid testing antigen kit manufactured by Coris BioConcept.

The company plans to launch the testing kit named, 'COVID-19 Ag Respi-Strip' at a price of Rs 425, Vishat Diagnostics said in a statement.

The kit tests for antibodies in users to determine whether they have had coronavirus infection in the past.

"With COVID-19 Ag Respi-Strip, we are bringing CE certified (allowed to sell in European Economic Area) and ICMR approved kits at affordable prices, which is also our company's driving force for all other product lines," Vishat Diagnostics MD Pratik Chaitala said.

At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing, he added.

COVID-19 Ag Respi-Strip can show results in a span of 15 minutes, the statement said.

The kit has been developed by Belgium-based firm Coris BioConcept, and is used in several European countries and in North America, it added.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medical Dialogues Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

ICMR nod to Vishat Diagnostics COVID-19 antigen testing kit priced at Rs 425

Similar News

CDSCO Panel Flags Inadequate Data, Withholds Pilot Study Nod for BPH Pulse Field Ablation Device

Morepen Medipath, Bimedical FZE to form JV company in India

Govt Amends Marketing Code for Medical Devices, Details

ICMR, CDSCO, Industry leaders emphasize collaboration, regulatory reforms to strengthen India's pharma leadership

GE HealthCare Revolution Vibe CT system gets USFDA clearance

India MedTech Expo 2025: DoP to hold second edition from 4th to 6th September

Minister calls for strong focus on RnD to produce affordable, high-quality medical devices

India making major strides towards self reliance in high end medical devices